Thursday, May 23, 2013

• Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease MedicineBusiness Wire( (Thu, May 23)

Wednesday, May 22, 2013

• Merck Statement on FDA Advisory Committee Meeting for SuvorexantBusiness Wire( (Wed, May 22)

Tuesday, May 21, 2013

• Merck Announces $5 Billion Accelerated Share RepurchaseBusiness Wire( (Tue, May 21)

Friday, May 17, 2013

• Merck to Present at the UBS Global Healthcare ConferenceBusiness Wire( (Fri, May 17)
• Global Health, Development and Business Leaders Announce New Innovative Financing Partnership to Deliver Essential Health Supplies More Quickly and EfficientlyBusiness Wire( (Fri, May 17)

Wednesday, May 15, 2013

• Merck Prices $ 6.5 Billion Debt OfferingBusiness Wire( (Wed, May 15)

Tuesday, May 14, 2013

• Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare ConferenceBusiness Wire( (Tue, May 14)

Thursday, May 9, 2013

• Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc.PR Newswire( (Thu, May 9)
• GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck’s HPV Vaccine, Available to Developing Countries through UNICEF TenderBusiness Wire( (Thu, May 9)

Wednesday, May 8, 2013

• Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy TabletBusiness Wire( (Wed, May 8)

Tuesday, May 7, 2013

• Merck and Celebrity Chef Art Smith "Cook Up a Recipe" for Better Type 2 Diabetes ManagementPR Newswire( (Tue, May 7)

Monday, May 6, 2013

• Merck Consumer Care Launches Health and Wellness Effort To Help Empower Moms To Live A More Active Lifestyle With Their FamiliesPR Newswire( (Mon, May 6)